Vasile Musteata|Василий Мустяцэ, Vasile Musteață

Vasile Musteata|Василий Мустяцэ, Vasile Musteață

”Nicolae Testemitanu” State University of Medicine and Pharmacy - Chișinău / Moldova
Medical and Health Sciences / Hematology
AD Scientific Index ID: 4757793
-
person_outline Vasile Musteata|Василий Мустяцэ, Vasile Musteață's MOST POPULAR ARTICLES
1-) Phase 2 multiple-dose study of an FcRn inhibitor, rozanolixizumab, in patients with primary immune thrombocytopeniaT Robak, M Kaźmierczak, I Jarque, V Musteata, J Treliński, N Cooper, ...Blood advances 4 (17), 4136-4146, 2020622020
2-) Phase II, multiple-dose study of anti-FcRn antibody, rozanolixizumab (UCB7665), in patients with primary immune thrombocytopenia: interim analysisT Robak, I Jarque, V Musteata, P Kiessling, U Massow, J Higginson, ...Blood 130, 15, 2017162017
3-) Targeted therapy of chronic myelogenous leukemia: experience of the Institute of Oncology of MoldovaV Musteata, I CorcimaruArchives of the Balkan Medical Union 43 (3), 154-155, 2008132008
4-) GIPAP în Republica Moldova: realizări şi perspectiveM Vasile, C Ion, S Mircea-Dumitru, M Larisa, R Maria, T Ludmila, C Maria, ...Buletinul Academiei de Ştiinţe a Moldovei. Ştiinţe Medicale 16 (2), 226-228, 2008122008
5-) A phase 2 study of MT-3724 to evaluate safety, pharmacodynamics and efficacy of MT-3724 for the treatment of patients with relapsed or refractory diffuse large B-cell lymphomaDO Persky, V Musteata, M Zodelava, T Perekhrestenko, AE Diaz, ...Blood 134, 5324, 201972019